United States · Financial press · Investor's Business Daily

Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist

Published by Investor's Business Daily · United States 1 h ago

Iovance stock crashed Thursday, undercutting its 50-day line, on new durability questions for its experimental lung cancer treatment. The post Iovance, A Top 1% Biotech Stock,…

Read the full article on Investor's Business Daily Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)

Also worth reading

The Wall Street Journal

ING Launches Buyback But Flags Job Cuts and Unit Restructuring

Barron's

Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist

Share

Also worth reading

ING Launches Buyback But Flags Job Cuts and Unit Restructuring

Fortinet Stock Sinks. Analysts Say a Key Revenue Driver May Have Peaked.